22.682 articles found

Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F.

Clin Interv Aging · 2010-09-07

DOI: 10.2147/cia.s6456PMID: 20852670

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).

Solla P, Cannas A, Marrosu F, Marrosu MG.

Neuropsychiatr Dis Treat · 2010-09-07

DOI: 10.2147/ndt.s5190PMID: 20856911

Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability.

Cubo E.

Clinicoecon Outcomes Res · 2010-09-06

DOI: 10.2147/ceor.s11996PMID: 21935322

Methods for the treatment of respiratory depression

MUELLER RUDOLF, STREET LESLIE.

· 2010-09-03

OXOPIPERAZINE DERIVATIVES FOR THE TREATMENT OF PAIN AND EPILEPSY

PAJOUHESH HASSAN, DING YANBING.

· 2010-09-03

The use of subcutaneous scopolamine as a palliative treatment in Parkinson's disease.

Pérez LM, Farriols C, Puente V, Planas J, Ruiz I.

Palliat Med · 2010-09-03

DOI: 10.1177/0269216310381662PMID: 20817746

METHOD OF TREATMENT OF NEURODEGENERATIVE OR NEURO-MUSCULAR DEGENERATIVE DISEASES AND THERAPEUTIC AGENT TO TREAT THE SAME

MEDASANI MUNISEKHAR, DIVI SATYASAYEE BABU, PALEMPATI SATYA LAXMI PRIYANKA.

· 2010-09-02

Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E.

Antioxid Redox Signal · 2010-09-01

DOI: 10.1089/ars.2009.3015PMID: 20156111

The iPS technique provides hope for Parkinson's disease treatment.

Xu L, Tan YY, Ding JQ, Chen SD.

Stem Cell Rev Rep · 2010-09-01

DOI: 10.1007/s12015-010-9145-2PMID: 20352528

Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases.

Figueiredo CP, Pamplona FA, Mazzuco TL, Aguiar AS, Walz R, Prediger RD.

Behav Pharmacol · 2010-09-01

DOI: 10.1097/fbp.0b013e32833c8544PMID: 20574409

New small molecules for the treatment of Parkinson's disease.

Müller T.

Expert Opin Investig Drugs · 2010-09-01

DOI: 10.1517/13543784.2010.504711PMID: 20645881

Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment.

Espay AJ, Paviour DC, O'Sullivan JD, Schmidt RE, Revilla FJ, Metman LV.

Mov Disord · 2010-09-01

DOI: 10.1002/mds.23194PMID: 20669183